Medical Oxygen Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

medical oxygen

nitrogenx limited - oxygen 99.5% - gas - 100 % - active: oxygen 99.5%

Iron Restore Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

iron restore

synogenx pty ltd - iron (ii) glycinate, quantity: 171.43 mg (equivalent: iron, qty 24 mg); cyanocobalamin, quantity: 50 microgram; ascorbic acid, quantity: 100 mg; menaquinone 7, quantity: 0.18 mg; folic acid, quantity: 0.4 mg - tablet, uncoated - excipient ingredients: isomalt; maltodextrin; magnesium stearate; colloidal anhydrous silica - maintain/support healthy growth and development ; helps enhance/promote general health and wellbeing ; maintain/support red blood cell health ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; aids/assists the body to cope with environmental stress ; maintain/support nervous system function

Immunosync Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

immunosync

synogenx pty ltd - lysine hydrochloride, quantity: 500 mg (equivalent: lysine, qty 400 mg); ascorbic acid, quantity: 200 mg; propolis dry extract, quantity: 100 mg (equivalent: propolis, qty 500 mg; equivalent: lead, qty 1 microgram); zinc amino acid chelate, quantity: 25 mg (equivalent: zinc, qty 5 mg); isatis tinctoria, quantity: 100 mg (equivalent: isatis tinctoria, qty 500 mg) - tablet, uncoated - excipient ingredients: isomalt; maltodextrin; magnesium stearate; colloidal anhydrous silica - maintain/support immune system health ; enhance/improve/promote immune defence/immunity ; maintain/support healthy immune system function ; maintain/support immune system to fight illness ; helps stimulate a healthy immune system response ; decrease/reduce/relieve symptoms of common colds and flu ; maintain/support lung health

FORFIVO  XL- bupropion hydrochloride tablet, film coated, extended release Estats Units - anglès - NLM (National Library of Medicine)

forfivo xl- bupropion hydrochloride tablet, film coated, extended release

edgemont pharmaceuticals, llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 450 mg - forfivo xl (bupropion hydrochloride extended-release tablets) is indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14) ]. the physician who elects to use forfivo xl for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient. risk summary data from epidemiological studies including pregnant women exposed to bupropion in the first trimester indicate no increased risk of congenital malformations. all pregnancies regardless o

FLUCET 5G CRM Índia - anglès - Central Drugs Standard Control Organization

flucet 5g crm

heterohc(genx) - fluticasone prop.,imidurea - crm - 0.05,0.2;%;w/w - 5g

VYVGART Israel - anglès - Ministry of Health

vyvgart

medison pharma ltd - efgartigimod alfa - concentrate for solution for infusion - efgartigimod alfa 20 mg/ml - efgartigimod - vyvgart is indicated for the treatment of generalized myasthenia gravis (gmg) in adult patients who are anti-acetylcholine receptor (achr) antibody positive.

BRACE RELIEF- benzocaine gel Estats Units - anglès - NLM (National Library of Medicine)

brace relief- benzocaine gel

infalab,inc - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5) -